Sentradine
Product Images NDC 68405-033

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sentradine (NDC 68405-033). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physician Therapeutics Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ranitidinelabel (Ranitidinelabel)

Ranitidinelabel (Ranitidinelabel)
Sentradine label showing Ranitidine 150mg tablet information including lot number RAN102QY, manufacturer AMNEALPHRM, and expiration date 08/11. The label compares the product to Zantac with manufacturer NDC 53746-0253-05. The label instructs to take as directed by your doctor or refer to the outsert for dosage information. Multiple small identical labels are shown on the right side.*
FDA Label Image

Ranitidine Structural Formula (Ranitidinestructuralformula)

Ranitidine Structural Formula (Ranitidinestructuralformula)
Chemical structure of the active ingredient for Sentradine, illustrating the molecular framework including heteroatoms, functional groups, and the hydrochloride (HCl) component.*
FDA Label Image

Sentra Pm (Sentrapm)

Sentra Pm (Sentrapm)
Label for Sentra PM Medical Food by Physician Therapeutics LLC showing product name and formulation as medical food. The label states it contains 60 capsules and is for Rx only. Directions specify use under medical supervision for adults, two capsules at bedtime. Ingredients include proprietary amino acid and herbal blends plus added compounds. Storage and warning information is provided along with distributor details.*
FDA Label Image

Sentradine (Sentradine)

Sentradine (Sentradine)
Packaging label for Sentradine, a convenience-packed medical food and drug product by Physician Therapeutics LLC. The label highlights a co-pack containing Sentra PM capsules (60 count) and Ranitidine 150 mg tablets (30 count). The product is Rx only with NDC 68405-033-26, and states no refills without physician authorization.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.